These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5271999)

  • 21. [Antimicrobial drug therapy and microbial sensitivity tests-- antitubercular agents and microbial sensitivity tests].
    Abe C
    Rinsho Byori; 1997 Jul; Suppl 105():191-5. PubMed ID: 9379539
    [No Abstract]   [Full Text] [Related]  

  • 22. [Differentiation of slow-growing scotochromogenous mycobacteria].
    Schröder KH; Pfirrmann K; Töpfer M; Hoff K
    Zentralbl Bakteriol Orig; 1971; 216(2):228-38. PubMed ID: 5551866
    [No Abstract]   [Full Text] [Related]  

  • 23. [Viability of the drug resistant Mycobacterium tuberculosis (study by the proportion method)].
    Belogurova VP; Ivanitskaia NN
    Antibiotiki; 1970 Nov; 15(11):1010-3. PubMed ID: 5497632
    [No Abstract]   [Full Text] [Related]  

  • 24. [Drug resistance of Mycobacterium tuberculosis during the cycloserine treatment of pulmonary tuberculosis patients].
    STEPANIAN ES; SERGEEV VV
    Probl Tuberk; 1962; 40(8)():84-7. PubMed ID: 13983851
    [No Abstract]   [Full Text] [Related]  

  • 25. Susceptibility of mycobacterium intracellulare to O-carbamyl-D-serine.
    David HL
    Am Rev Respir Dis; 1970 Jul; 102(1):105-6. PubMed ID: 5427392
    [No Abstract]   [Full Text] [Related]  

  • 26. [The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains].
    Kayali R; Cöplü N; Ceyhan I; Ocak F; Citil BE; Esen B
    Mikrobiyol Bul; 2006; 40(1-2):1-7. PubMed ID: 16775950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutants with altered DNA base composition in Bacterium paracoli--the evidence from a marker.
    Gause GF; Laiko AV; Bibikova MV; Kusovkova LI; Selesneva TI; Dudnik YV
    Z Allg Mikrobiol; 1971; 11(2):91-5. PubMed ID: 5563616
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of cycloserine as an antituberculous drug.
    Gomi J
    Scand J Respir Dis Suppl; 1970; 71():130-2. PubMed ID: 5317742
    [No Abstract]   [Full Text] [Related]  

  • 29. [Editorial: Mycobacterial drug resistance in the German Democratic Republic].
    Steinbrück P
    Z Erkr Atmungsorgane; 1974; 140(3):264-5. PubMed ID: 4499424
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical mycobacteriology. Drug susceptibility testing.
    Heifets LB
    Clin Lab Med; 1996 Sep; 16(3):641-56. PubMed ID: 8866184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN; Barrera L
    Medicina (B Aires); 2007; 67(3):231-7. PubMed ID: 17628909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [True Mycobacterium tuberculosis drug resistance].
    Terentieva AS
    Probl Tuberk; 1981 Mar; (3):67-9. PubMed ID: 6785746
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T; Drlica K
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and antimycobacterial activity of some 4-pyridinecarboxyamidrazone derivatives.
    Mamolo MG; Vio L; Banfi E; Predominato M; Fabris C; Asaro F
    Farmaco; 1993 Apr; 48(4):529-38. PubMed ID: 8357468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The change in drug resistance of resistant Mycobacterium tuberculosis H37Rv strains after successive transfers on Ogawa medium for seven years].
    Yamadori H; Shibata A; Inagake H
    Bull Chest Dis Res Inst Kyoto Univ; 1984 Mar; 17(1-2):20-5. PubMed ID: 6442171
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the drug resistance of Myc. tuberculosis isolated from patients with primary pulmonary tuberculosis. Bacteriological and clinical observations].
    ZORZOLI P; MONCALVO F
    G Ital Tuberc Mal Torace; 1962; 16():219-passim. PubMed ID: 14003952
    [No Abstract]   [Full Text] [Related]  

  • 37. [Some clinical aspects of microbial resistance to antibiotics].
    Modr Z
    Cas Lek Cesk; 1971; 110(34):785-9. PubMed ID: 5570006
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacological considerations on cycloserine.
    Curci C
    Scand J Respir Dis Suppl; 1970; 71():51-60. PubMed ID: 4989522
    [No Abstract]   [Full Text] [Related]  

  • 39. [Interactions of antitubercular drugs. II. Combined effects of rifampin, ethambutol, capreomycin, viomycin, ethionamide and cycloserine on mycobacterial growth in vitro].
    Janowiec M; Zwolska-Kwiek Z
    Pneumonol Pol; 1983 Dec; 51(12):607-12. PubMed ID: 6199778
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mycobacterium kansasii and its variants].
    Schröder KH; Magnusson M
    Zentralbl Bakteriol Orig; 1968; 207(4):498-509. PubMed ID: 5742980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.